ARMISTICE CAPITAL, LLC - REVIVA PHARMACEUTCLS HLDGS I ownership

REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 30 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q1 2024. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of REVIVA PHARMACEUTCLS HLDGS I
ValueSharesWeighting
Q4 2023$9,084,600
+210.3%
1,764,000
+194.0%
0.12%
+175.6%
Q3 2023$2,928,000
-39.4%
600,000
-27.2%
0.04%
-35.7%
Q2 2023$4,828,640
+136.1%
824,000
+16.5%
0.07%
+112.1%
Q4 2021$2,045,000
-20.3%
707,578
+12.2%
0.03%
-23.3%
Q3 2021$2,567,000
-26.1%
630,700
-11.8%
0.04%
-30.6%
Q2 2021$3,473,000714,7000.06%
Other shareholders
REVIVA PHARMACEUTCLS HLDGS I shareholders Q1 2024
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,200,000$2,952,0000.59%
EMC Capital Management 55,078$135,0000.10%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Renaissance Technologies 12,700$31,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 9,299$23,0000.00%
WELLS FARGO & COMPANY/MN 102$00.00%
GEODE CAPITAL MANAGEMENT, LLC 78,075$192,0000.00%
BANK OF AMERICA CORP /DE/ 2$00.00%
RAYMOND JAMES & ASSOCIATES 14,000$34,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 659$1,0000.00%
View complete list of REVIVA PHARMACEUTCLS HLDGS I shareholders